Actively Recruiting
Hormone Replacement Therapy After Risk Reducing Salpingo-oophorectomy
Led by Duke University · Updated on 2026-03-27
50
Participants Needed
2
Research Sites
65 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this study is to develop an educational aid about hormone replacement therapy that physicians can share with patients as part of their pre-surgical counseling for a risk-reducing salpingo-oophorectomy (RRSO).
CONDITIONS
Official Title
Hormone Replacement Therapy After Risk Reducing Salpingo-oophorectomy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Have a BRCA1 or BRCA2 germline mutation
- Scheduled for a risk-reducing salpingo-oophorectomy (RRSO) by a Duke Gynecologic Oncologist
- Premenopausal
- Female
- Between 19 and 50 years old
You will not qualify if you...
- Personal history of cancer
- Postmenopausal
- Older than 50 years
- Unable to provide informed consent in English
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
UNC Chapel Hill Health System
Chapel Hill, North Carolina, United States, 27514
Actively Recruiting
2
Duke University Health System
Durham, North Carolina, United States, 27710
Actively Recruiting
Research Team
A
Amelia Scott
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here